Systematic Influence of Circulating Bilirubin Levels on Osteoporosis

Observational studies report some association between circulating bilirubin levels and osteoporosis, but it is unknown if this association is causal or confounded. In this two-sample Mendelian randomization (MR) study, we included a large genome-wide association study (GWAS) associated with total bi...

Full description

Bibliographic Details
Main Authors: Jinqiu Zhao, Muzi Zhang, Zhengxue Quan, Liang Deng, Yongguo Li, Bin He
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2021.719920/full
_version_ 1824043731199721472
author Jinqiu Zhao
Muzi Zhang
Zhengxue Quan
Liang Deng
Yongguo Li
Bin He
author_facet Jinqiu Zhao
Muzi Zhang
Zhengxue Quan
Liang Deng
Yongguo Li
Bin He
author_sort Jinqiu Zhao
collection DOAJ
description Observational studies report some association between circulating bilirubin levels and osteoporosis, but it is unknown if this association is causal or confounded. In this two-sample Mendelian randomization (MR) study, we included a large genome-wide association study (GWAS) associated with total bilirubin levels among 317,639 people, a large meta-analysis to identify genetic variants associated with bone mineral density (BMD) estimated by heel quantitative ultrasound (eBMD) among 426,824 individuals and fracture among 1.2 million individuals. The results revealed that circulating bilirubin levels had no causal influence on eBMD (beta-estimate: 0.004, 95% confidence interval [CI]: -0.019 to 0.028, SE:0.012, P-value=0.705) or the risk of fracture (beta-estimate: -0.009, 95% CI: -0.035 to 0.017, SE:0.013, P-value=0.488), which were both confirmed by multiple sensitivity analyses. Our results confirm that circulating bilirubin levels have no causal role in eBMD or the incidence of fracture, indicating that circulating bilirubin levels is unlikely to be a causal risk factor for osteoporosis or fracture.
first_indexed 2024-12-22T23:59:55Z
format Article
id doaj.art-399975cfb73e42739a6989ea0b7d306d
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-12-22T23:59:55Z
publishDate 2021-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-399975cfb73e42739a6989ea0b7d306d2022-12-21T18:07:50ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922021-08-011210.3389/fendo.2021.719920719920Systematic Influence of Circulating Bilirubin Levels on OsteoporosisJinqiu Zhao0Muzi Zhang1Zhengxue Quan2Liang Deng3Yongguo Li4Bin He5Department of Infectious Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Orthopedics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Orthopedics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Gastroenterology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Infectious Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Orthopedics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaObservational studies report some association between circulating bilirubin levels and osteoporosis, but it is unknown if this association is causal or confounded. In this two-sample Mendelian randomization (MR) study, we included a large genome-wide association study (GWAS) associated with total bilirubin levels among 317,639 people, a large meta-analysis to identify genetic variants associated with bone mineral density (BMD) estimated by heel quantitative ultrasound (eBMD) among 426,824 individuals and fracture among 1.2 million individuals. The results revealed that circulating bilirubin levels had no causal influence on eBMD (beta-estimate: 0.004, 95% confidence interval [CI]: -0.019 to 0.028, SE:0.012, P-value=0.705) or the risk of fracture (beta-estimate: -0.009, 95% CI: -0.035 to 0.017, SE:0.013, P-value=0.488), which were both confirmed by multiple sensitivity analyses. Our results confirm that circulating bilirubin levels have no causal role in eBMD or the incidence of fracture, indicating that circulating bilirubin levels is unlikely to be a causal risk factor for osteoporosis or fracture.https://www.frontiersin.org/articles/10.3389/fendo.2021.719920/fullosteoporosiscirculating bilirubin levelsBMDfractureMendelian randomization study
spellingShingle Jinqiu Zhao
Muzi Zhang
Zhengxue Quan
Liang Deng
Yongguo Li
Bin He
Systematic Influence of Circulating Bilirubin Levels on Osteoporosis
Frontiers in Endocrinology
osteoporosis
circulating bilirubin levels
BMD
fracture
Mendelian randomization study
title Systematic Influence of Circulating Bilirubin Levels on Osteoporosis
title_full Systematic Influence of Circulating Bilirubin Levels on Osteoporosis
title_fullStr Systematic Influence of Circulating Bilirubin Levels on Osteoporosis
title_full_unstemmed Systematic Influence of Circulating Bilirubin Levels on Osteoporosis
title_short Systematic Influence of Circulating Bilirubin Levels on Osteoporosis
title_sort systematic influence of circulating bilirubin levels on osteoporosis
topic osteoporosis
circulating bilirubin levels
BMD
fracture
Mendelian randomization study
url https://www.frontiersin.org/articles/10.3389/fendo.2021.719920/full
work_keys_str_mv AT jinqiuzhao systematicinfluenceofcirculatingbilirubinlevelsonosteoporosis
AT muzizhang systematicinfluenceofcirculatingbilirubinlevelsonosteoporosis
AT zhengxuequan systematicinfluenceofcirculatingbilirubinlevelsonosteoporosis
AT liangdeng systematicinfluenceofcirculatingbilirubinlevelsonosteoporosis
AT yongguoli systematicinfluenceofcirculatingbilirubinlevelsonosteoporosis
AT binhe systematicinfluenceofcirculatingbilirubinlevelsonosteoporosis